Measurement and meaning of apolipoprotein AI and apolipoprotein B plasma levels (Q36455881)

14 August 2017

1 reference

title

Measurement and meaning of apolipoprotein AI and apolipoprotein B plasma levels (English)

1 reference

14 August 2017

Marcovina S

1

1 reference

PubMed ID

16629849

14 August 2017

Packard CJ

series ordinal

2

1 reference

PubMed ID

16629849

14 August 2017

language of work or name

English

0 references

publication date

1 May 2006

1 reference

Journal of Internal Medicine

14 August 2017

1 reference

14 August 2017

259

1 reference

14 August 2017

437-446

1 reference

14 August 2017

5

1 reference

Lipoprotein heterogeneity and apolipoprotein B metabolism

14 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01648.X

Postprandial lipoprotein metabolism and atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01648.X

Remodelling of high density lipoproteins by plasma factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01648.X

New insights into the regulation of HDL metabolism and reverse cholesterol transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01648.X

ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01648.X

Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01648.X

Differences between markers of atherogenic lipoproteins in predicting high cardiovascular risk and subclinical atherosclerosis in asymptomatic men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01648.X

Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01648.X

Dyslipidemia in visceral obesity: mechanisms, implications, and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01648.X

TRL, IDL, and LDL apolipoprotein B-100 and HDL apolipoprotein A-I kinetics as a function of age and menopausal status

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01648.X

Diabetic dyslipidaemia: from basic research to clinical practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01648.X

Cholesterol metabolism and therapeutic targets: rationale for targeting multiple metabolic pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01648.X

Comparison of apolipoprotein B metabolism in familial defective apolipoprotein B and heterogeneous familial hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01648.X

Remnant lipoproteins as therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01648.X

Metabolic origins and clinical significance of LDL heterogeneity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01648.X

Structure-function relationships in apolipoprotein(a): insights into lipoprotein(a) assembly and pathogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01648.X

Lipoprotein(a) and coronary heart disease. Meta-analysis of prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01648.X

High density lipoproteins (HDLs) and atherosclerosis; the unanswered questions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01648.X

Stimulation of fecal steroid excretion after infusion of recombinant proapolipoprotein A-I. Potential reverse cholesterol transport in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01648.X

Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01648.X

Plasma lipoproteins and apolipoproteins as predictors of cardiovascular risk and treatment benefit in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01648.X

10.1111/J.1365-2796.2006.01648.X

21 January 2018

Identifiers

DOI

1 reference

14 August 2017

1 reference

PubMed ID

16629849